Lever Bio vision is to unlock biotech innovation in immuno-oncology working with researchers , universities and research centers.
Lever Bio has raised $5.9M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Lever Bio's investors include Claris Ventures, Ora Global.
Lever Bio is headquartered in Turin, Italy.
Lever Bio vision is to unlock biotech innovation in immuno-oncology working with researchers , universities and research centers.
Lever Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lever Bio — Funding & Investors." VCBacked, December 22, 2025, https://www.vcbacked.co/company/lever-bio. Accessed August 2, 2026.
VCBacked. (2025). Lever Bio — Funding & Investors. Retrieved August 2, 2026, from https://www.vcbacked.co/company/lever-bio
{{cite web |title=Lever Bio — Funding & Investors |url=https://www.vcbacked.co/company/lever-bio |website=VCBacked |access-date=August 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated